1. Home
  2. SAMG vs SCPH Comparison

SAMG vs SCPH Comparison

Compare SAMG & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAMG
  • SCPH
  • Stock Information
  • Founded
  • SAMG 2002
  • SCPH 2013
  • Country
  • SAMG United States
  • SCPH United States
  • Employees
  • SAMG N/A
  • SCPH N/A
  • Industry
  • SAMG Investment Managers
  • SCPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • SAMG Finance
  • SCPH Health Care
  • Exchange
  • SAMG Nasdaq
  • SCPH Nasdaq
  • Market Cap
  • SAMG 151.1M
  • SCPH 173.6M
  • IPO Year
  • SAMG 2013
  • SCPH 2017
  • Fundamental
  • Price
  • SAMG $16.36
  • SCPH $5.08
  • Analyst Decision
  • SAMG
  • SCPH Strong Buy
  • Analyst Count
  • SAMG 0
  • SCPH 3
  • Target Price
  • SAMG N/A
  • SCPH $14.00
  • AVG Volume (30 Days)
  • SAMG 21.0K
  • SCPH 307.7K
  • Earning Date
  • SAMG 07-31-2025
  • SCPH 08-13-2025
  • Dividend Yield
  • SAMG 4.90%
  • SCPH N/A
  • EPS Growth
  • SAMG N/A
  • SCPH N/A
  • EPS
  • SAMG 0.94
  • SCPH N/A
  • Revenue
  • SAMG $124,771,000.00
  • SCPH $41,982,000.00
  • Revenue This Year
  • SAMG $3.93
  • SCPH $108.95
  • Revenue Next Year
  • SAMG $5.56
  • SCPH $73.83
  • P/E Ratio
  • SAMG $17.37
  • SCPH N/A
  • Revenue Growth
  • SAMG 5.51
  • SCPH 138.10
  • 52 Week Low
  • SAMG $13.54
  • SCPH $1.94
  • 52 Week High
  • SAMG $19.20
  • SCPH $6.28
  • Technical
  • Relative Strength Index (RSI)
  • SAMG 52.99
  • SCPH 58.22
  • Support Level
  • SAMG $16.19
  • SCPH $5.37
  • Resistance Level
  • SAMG $16.72
  • SCPH $5.70
  • Average True Range (ATR)
  • SAMG 0.33
  • SCPH 0.31
  • MACD
  • SAMG -0.08
  • SCPH -0.00
  • Stochastic Oscillator
  • SAMG 36.46
  • SCPH 39.09

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

Share on Social Networks: